Experimental group:Dialectical governance based on ''three parties''

2 trials

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine)

Conditions

Delta Novel Coronavirus Pneumonia

Unknown Phase

A multi-center, open-label, randomized controlled clinical trial study on the treatment of Delta novel coronavirus pneumonia (COVID-19) based on ''three-party'' syndrome differentiation and treatment

RecruitingChiCTR2100049665

Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine)Delta Novel Coronavirus Pneumonia

Start: 2021-08-07Updated: 2022-04-19

A multi-center, open-label, randomized controlled clinical trial study on the treatment of Delta novel coronavirus pneumonia (COVID-19) based on ''three-party'' syndrome differentiation and treatment

RecruitingITMCTR2100005149

Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine)Delta Novel Coronavirus Pneumonia

Start: 2021-08-07Updated: 2023-02-20